Hepatic circulation: potential for therapeutic intervention
- PMID: 2203072
- PMCID: PMC7133670
- DOI: 10.1016/0163-7258(90)90091-f
Hepatic circulation: potential for therapeutic intervention
Abstract
In recent years, knowledge of the physiology and pharmacology of hepatic circulation has grown rapidly. Liver microcirculation has a unique design that allows very efficient exchange processes between plasma and liver cells, even when severe constraints are imposed upon the system, i.e. in stressful situations. Furthermore, it has been recognized recently that sinusoids and their associated cells can no longer be considered only as passive structures ensuring the dispersion of molecules in the liver, but represent a very sophisticated network that protects and regulates parenchymal cells through a variety of mediators. Finally, vascular abnormalities are a prominent feature of a number of liver pathological processes, including cirrhosis and liver cell necrosis whether induced by alcohol, ischemia, endotoxins, virus or chemicals. Although it is not clear whether vascular lesions can be the primary events that lead to hepatocyte injury, the main interest of these findings is that liver microcirculation could represent a potential target for drug action in these conditions.
Similar articles
-
Cooperation of liver cells in health and disease.Adv Anat Embryol Cell Biol. 2001;161:III-XIII, 1-151. doi: 10.1007/978-3-642-56553-3. Adv Anat Embryol Cell Biol. 2001. PMID: 11729749 Review.
-
Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats.J Hepatol. 2000 Oct;33(4):555-63. doi: 10.1034/j.1600-0641.2000.033004555.x. J Hepatol. 2000. PMID: 11059860
-
Effect of notoginsenoside R1 on hepatic microcirculation disturbance induced by gut ischemia and reperfusion.World J Gastroenterol. 2008 Jan 7;14(1):29-37. doi: 10.3748/wjg.14.29. World J Gastroenterol. 2008. PMID: 18176958 Free PMC article.
-
Heme oxygenase (HO)-1 protects from lipopolysaccharide (LPS)-mediated liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion.Langenbecks Arch Surg. 2010 Apr;395(4):387-94. doi: 10.1007/s00423-010-0603-8. Epub 2010 Mar 17. Langenbecks Arch Surg. 2010. PMID: 20237939
-
Hepatic microvasculature in liver injury.Semin Liver Dis. 2007 Nov;27(4):390-400. doi: 10.1055/s-2007-991515. Semin Liver Dis. 2007. PMID: 17979075 Review.
Cited by
-
Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?Clin Rev Allergy Immunol. 2021 Jun;60(3):318-347. doi: 10.1007/s12016-021-08851-8. Epub 2021 Mar 16. Clin Rev Allergy Immunol. 2021. PMID: 33725263 Free PMC article. Review.
-
Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics.Int J Nanomedicine. 2014 Jan 24;9:695-710. doi: 10.2147/IJN.S55255. eCollection 2014. Int J Nanomedicine. 2014. PMID: 24493926 Free PMC article.
-
Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits.J Clin Invest. 1994 Jun;93(6):2691-700. doi: 10.1172/JCI117283. J Clin Invest. 1994. PMID: 8201006 Free PMC article.
-
Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA.Front Bioeng Biotechnol. 2020 Jun 10;8:512. doi: 10.3389/fbioe.2020.00512. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32587849 Free PMC article.
-
BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.J Pharmacokinet Pharmacodyn. 2012 Feb;39(1):37-54. doi: 10.1007/s10928-011-9229-x. Epub 2011 Dec 10. J Pharmacokinet Pharmacodyn. 2012. PMID: 22161221 Free PMC article.
References
-
- Abecassis M., Falk J.A., Makowka L., Dindzans V.J., Falk R.E., Levy G.Z. 16,16 dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J. clin. Invest. 1987;80:881–889. - PMC - PubMed
-
- Ahmad A.B., Bennett P.N., Rowland M. Influence of route of hepatic administration on drug availability. J. Pharmac. exp. Ther. 1984;230:718–725. - PubMed
-
- Akerboom T., Lenzen R., Schneider I., Sies H. Cholestasis and changes in the microcirculation of perfused rat liver caused by the calcium ionophore A 23187 and type I antiarrhythmic drugs. Biochem. Pharmac. 1987;36:3037–3042. - PubMed
-
- Altin J.G., Bygrave F.L. Non-parenchymal cells as mediators of physiological responses in liver. Molec. cell. Biochem. 1988;83:3–4. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical